Dov Elefant's Net Worth
-$935
Who is Dov Elefant?
Dov Elefant does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FEMASYS INC, Lev Pharmaceuticals Inc, Akari Therapeutics Plc, Cellectar Biosciences, Inc., and EPICEPT CORP.
SEC CIK
Dov Elefant's CIK is 0001326487
Past Insider Trading and Trends
2020 was Dov Elefant's most active year for acquiring shares with 5 total transactions. Dov Elefant's most active month to acquire stocks was the month of January. 2007 was Dov Elefant's most active year for disposing of shares, totalling 1 transactions. Dov Elefant's most active month to dispose stocks was the month of February. 2020 saw Dov Elefant paying a total of $42,099.65 for 33,929 shares, this is the most they've acquired in one year. In 2007 Dov Elefant cashed out on 200,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FEMASYS INC (FEMY) Snapshot price: $1.18
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lev Pharmaceuticals Inc No price found
Corporate Controller
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akari Therapeutics Plc (AKTX) Snapshot price: $2.94
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cellectar Biosciences, Inc. (CLRB) Snapshot price: $3.5
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +170.35% | 7.41K |
$1.35 | $9,999.45 | 11.76K |
Dec 28
| |||
Form 4
|
∞
| 4.35K |
$1.15 | $4,978.46 | 4.35K |
Jun 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
∞
| 10K |
$2.71 | $27,100.00 | 10K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPICEPT CORP No price found
Controller - VP - Fin & Admin
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||